149 related articles for article (PubMed ID: 23726257)
1. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
Ni Q; Jia H; Zhang Y; Lu J; Chang H
Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
[TBL] [Abstract][Full Text] [Related]
3. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Wang D; Su C; Li H; Guo X
Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract][Full Text] [Related]
5. New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.
Iida H; Kaibori M; Hirokawa F; Inoue Y; Ueno M; Matsui K; Ishizaki M; Tanaka S; Takemura S; Nomi T; Hokutou D; Noda T; Eguchi H; Nakai T; Maehira H; Mori H; Tani M; Kubo S
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2903-2911. PubMed ID: 33112547
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.
Memon K; Kulik LM; Lewandowski RJ; Wang E; Wang J; Ryu RK; Hickey R; Vouche M; Baker T; Ganger D; Gates VL; Habib A; Mulcahy MF; Salem R
J Vasc Interv Radiol; 2014 Jul; 25(7):1056-66. PubMed ID: 24613269
[TBL] [Abstract][Full Text] [Related]
7. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion.
Mai RY; Zeng J; Meng WD; Lu HZ; Liang R; Lin Y; Wu GB; Li LQ; Ma L; Ye JZ; Bai T
BMC Cancer; 2021 Mar; 21(1):283. PubMed ID: 33726693
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes of Hepatic Resection Combined With Intraoperative Ablation
Ikuta S; Aihara T; Kasai M; Nakajima T; Yamanaka N
Anticancer Res; 2024 May; 44(5):2133-2140. PubMed ID: 38677724
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
[TBL] [Abstract][Full Text] [Related]
11. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
Ho EY; Cozen ML; Shen H; Lerrigo R; Trimble E; Ryan JC; Corvera CU; Monto A;
HPB (Oxford); 2014 Aug; 16(8):758-67. PubMed ID: 24467780
[TBL] [Abstract][Full Text] [Related]
12. The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.
Manne A; Mulekar M; Escobar D; Prodduturvar P; Fahmawi Y; Henderson P; Abdul-Rahim O; Hussain Z; Liles S; Fonseca A; Howard JH; Mneimneh W; Gilbert R; Alkharabsheh O; Pai S; White ZB; Nelson C; Khushman M
J Cancer Res Ther; 2023; 19(5):1103-1108. PubMed ID: 37787270
[TBL] [Abstract][Full Text] [Related]
13. Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy.
Qiao G; Cucchetti A; Li J; Cescon M; Ercolani G; Liu G; Pinna AD; Li L; Shen F; Ren J
Oncotarget; 2016 May; 7(21):30408-19. PubMed ID: 27007152
[TBL] [Abstract][Full Text] [Related]
14. HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer.
Chang ML; Lin SM; Yeh CT
PLoS One; 2011; 6(10):e26323. PubMed ID: 22022601
[TBL] [Abstract][Full Text] [Related]
15. Clinical Relevance of Reductive Hepatectomy for Barcelona Clinic Liver Cancer Stages B and C Advanced Hepatocellular Carcinoma: A Single-Center Experience of 102 Patients.
Komatsu S; Kido M; Tanaka M; Kuramitsu K; Tsugawa D; Awazu M; Gon H; Toyama H; Ueno K; Fukumoto T
World J Surg; 2019 Oct; 43(10):2571-2578. PubMed ID: 31222640
[TBL] [Abstract][Full Text] [Related]
16. Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma.
Ku Y; Iwasaki T; Tominaga M; Fukumoto T; Takahashi T; Kido M; Ogata S; Takahashi M; Kuroda Y; Matsumoto S; Obara H
Ann Surg; 2004 Jan; 239(1):53-60. PubMed ID: 14685100
[TBL] [Abstract][Full Text] [Related]
17. Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging.
Dong H; Yang L; Shaofeng D; Lili G
Technol Cancer Res Treat; 2024; 23():15330338241245943. PubMed ID: 38660703
[TBL] [Abstract][Full Text] [Related]
18. Proper position of single and large (≥5 cm) hepatocellular carcinoma in Barcelona Clinic Liver Cancer classification.
Kim HS; Choi SJN; Lee HK;
Medicine (Baltimore); 2023 Oct; 102(41):e34639. PubMed ID: 37832135
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy.
Ielasi L; Stefanini B; Conti F; Tonnini M; Tortora R; Magini G; Sacco R; Pressiani T; Trevisani F; Foschi FG; Piscaglia F; Granito A; Tovoli F
Curr Oncol; 2024 Jan; 31(1):547-557. PubMed ID: 38275831
[TBL] [Abstract][Full Text] [Related]
20. Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study.
Kim BH; Park JW; Nam BH; Kwak HW; Kim WR
Liver Int; 2014 Aug; 34(7):e317-23. PubMed ID: 24606128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
